ARTICLE | Clinical News
ItMSCs: Phase III started
February 24, 2014 8:00 AM UTC
Stemedica's CardioCell LLC subsidiary said Kazakhstan's National Scientific Medical Center began a Kazakhstani Phase III trial to evaluate IV itMSCs in about 120 patients with acute MI. Altaco XXI (As...